Form 4: Eterna Therapeutics CEO Receives Stock Grant
Insider Transaction (Form 4)
Sanjeev Luther, President and CEO and a Director of Eterna Therapeutics Inc., received 118,848 shares of common stock on August 31, 2026.
Summary
- Grant/award: acquired 118,848 Stock Option (right to buy) on August 31, 2026; holds 118,848 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sanjeev Luther — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant/award | Stock Option (right to buy) | 118,848 | — | — | 118,848 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Grant/award (118,848 shares) |
Keywords
insider transaction, Form 4, ERNA, Ernexa Therapeutics Inc., neutral, Sanjeev Luther
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.